F. Kleinclauss

Centre Hospitalier Universitaire de Besançon, Inserm

Papers

4

Total Citations

43

H-Index

3

About

F. Kleinclauss is a prominent figure in urology and renal transplantation, with research spanning innovative cancer therapies and advanced surgical techniques. His major contributions include pioneering work on vascular targeted photodynamic therapy (VTP) with Padeliporfin for localized prostate cancer, notably demonstrating the feasibility and safety of radical prostatectomy following this novel treatment in a 2018 study (26 citations). This work has opened new avenues for combining minimally invasive therapies with curative surgery. In renal transplantation, Kleinclauss has addressed critical challenges, authoring influential French-language reviews on kidney transplantation challenges (9 citations), living donor transplantation (5 citations), and robot-assisted kidney transplantation (3 citations). These contributions highlight his role in advancing both oncologic and transplant surgery, particularly through the adoption of robotic techniques to improve patient outcomes. His research, though modest in citation counts, reflects a focused expertise in integrating emerging technologies into clinical practice, making him a valuable resource for students and researchers interested in the intersection of urologic oncology and transplant innovation.

Research Focus

Key Achievements

3
H-Index
4
Papers
43
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results
26 citations · 2018
📈 Most Prolific Year: 2016 (3 Papers)
🤝 Key Collaborators: 43
🏛 Institutions: Centre Hospitalier Universitaire de Besançon, Inserm

Top Papers

  1. 1
  2. 2
  3. 3
    Le donneur vivant de rein
    5 citations · 2016
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago